IntroductionLiaison psychiatry is the branch of psychiatry that specialises in the interface between medicine and psychiatry. The liaison psychiatrist uses a wide range of drugs and antipsychotics are among them.ObjectivesTo analyse the prescription of antipsychotics at the liaison psychiatry service of a general hospital.MethodsThis is a transversal study. All patients evaluated by the liaison psychiatry service of a general hospital from the 1/01/2012 to the 31/05/2012 were included.ResultsThe sample consisted of 128 patients (53’1% women; mean age 65’34±17’18). The majority of them were Spanish (92’2%). Internal Medicine was the service who asked for more psychiatric evaluations, followed by General Surgery (19’5%) and Nephrology (10’2%). The most frequent main complain was depression (46’9%), behavioural disorders (18%) and anxiety (10’2%). The diagnosis given were more often affective disorders (43’8%), delirium (11’7%), psychotic disorders (10’9%) and anxious disorders (9’4%).Within the 128 patients, 34 (26’6%) did receive antipsychotics during the admission. We compared the two groups (antipsychotic group vs non-antipsychotic group) and obtained the following results: we found that the antipsychotic group more often had behavioural disorders (34’3%) and delusions/hallucinations (20%). A significant increase in delirium diagnose was to be seen (42’9%).ConclusionsAntipsyhotics are the second most used treatment at the liaison psychiatry service. Patients who receive them are more often affected by delirium and to a minor extent by a psychotic disorder. The first generation antipsychotics such as haloperidol still are the first option. However, the use of second generation antipsychotics is increasing remarkably.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.